| Cat.No. |
Product Name |
Information |
Publication |
Customer Review |
| S1078 |
MK-2206 2HCl |
MK-2206 2HCl is a highly selective inhibitor of Akt1, Akt2 and Akt3 with IC50 of 8 nM, 12 nM and 65 nM, respectively.
|
(41)
|
(6)
|
| S1037 |
Perifosine |
Perifosine (KRX-0401) is a novel Akt inhibitor with IC50 of 4.7 μM.
|
(17)
|
(9)
|
| S1113 |
GSK690693 |
GSK690693 is a pan-Akt inhibitor targeting Akt1, Akt2 and Akt3 with IC50 of 2 nM, 13 nM, and 9 nM, respectively.
|
(2)
|
(1)
|
| S2808 |
GDC-0068 |
GDC-0068 is a highly selective pan-Akt inhibitor targeting Akt1, Akt2 and Akt3 with IC50 of 5 nM, 18 nM and 8 nM, respectively.
|
|
|
| S2743 |
PF-04691502 |
PF-04691502 is an ATP-competitive PI3K/mTOR inhibitor with IC50 of 32 nM and also inhibits Akt T308/S473 with IC50 of 7.5 nM/3.8 nM.
|
|
(1)
|
| S1558 |
AT7867 |
AT7867 is a potent ATP-competitive inhibitor of Akt1/2/3 and S6K with IC50 of 32 nM/17 n/47 nM and 85 nM, respectively.
|
(3)
|
(4)
|
| S1117 |
Triciribine |
Triciribine (TCN, API-2) is a DNA synthesis inhibitor and also inhibits Akt and HIV-1 with IC50 of 130 nM and 20 nM, respectively.
|
|
|
| S7127 |
TIC10 |
|
|
|
| S8019 |
AZD5363 |
AZD5363 is a potent Akt inhibitor for Akt1, Akt2 and Akt3 with IC50 of 3 nM, 8 nM and 8 nM, respectively.
|
|
|
| S3056 |
Miltefosine (Hexadecylphosphocholine) |
Miltefosine inhibits PI3K/Akt activity with ED50 of 17.2 μM and 8.1 μM in carcinoma cell lines A431 and HeLa.
|
|
|
| S2732 |
Triciribine phosphate (NSC-280594) |
Triciribine phosphate (TCN-P, NSC-280594, API-2) is a potent Akt inhibitor with IC50 of 130 nM.
|
|
|
| S2670 |
A-674563 |
A-674563 inhibits Akt1, PKA and CDK2 with Ki of 11 nM, 16 nM and 46 nM, respectively.
|
|
(1)
|
| S2635 |
CCT128930 |
CCT128930 is a potent, ATP-competitive and selective inhibitor of Akt2 with IC50 of 6 nM.
|
|
|
| S2310 |
Honokiol |
Honokiol is a biphyl neolignan present in the cones, bark, and leaves of Magnolia grandifloris that displays antiangiogenic, antiinflammatory, and antitumor properties due to the inhibitory effect on the PI3K/Akt pathway.
|
|
|
| S1556 |
PHT-427 |
PHT-427 is a dual Akt and PDPK1 inhibitor with Ki of 2.7 μM and 5.2 μM, respectively.
|
(1)
|
(2)
|